研究者学術情報データベース

ハットリ　ナオキ
服部　尚樹
HATTORI Naoki

所属薬学部薬学科

職名教授

論文
1.	2020/09	Re‐evaluation of serum leptin and adiponectin concentrations normalized by body fat mass in patients with rheumatoid arthritis │ Scientific Reports │ (共著)
2.	2019/10	Procedures for the diagnosis of macro-follicle stimulating hormone (FSH) in a patient with high serum FSH concentrations │ Clinical Chemistry and Laboratory Medicine │ 58 (2),e40-e43 (共著)
3.	2019	実務実習事前学習における効果的な呼吸器機能評価実習の取り組み │ 薬学教育　 │ 3,1-5 (共著)
4.	2018/10	Current Thyrotropin Immunoassays Recognize Macro-Thyrotropin Leading to Hyperthyrotropinemia in Females of Reproductive Age. │ Thyroid │ 28 (10),1252-1260 (共著)
5.	2018/04	効果的なフィジカルアセスメント学習の工夫～血圧・脈拍測定における運動負荷の導入 │ 薬学教育 │ 2 (共著)
6.	2017/02	Anti-TSH autoantibodies in patients with macro-TSH and long-term changes in macro-TSH and serum TSH levels │ Thyroid │ 27 (2),138-146 (共著)
7.	2016	A possible cause of the variable detectability of macroprolactin by different immunoassay systems │ Clinical Chemistry and Laboratory Medicine │ 54,603-608 (共著)
8.	2016	Variability in the detection of macro TSH in different immunoassay systems. │ European Journal of Endocrinology │ 174,9-15 (共著)
9.	2015	Macro TSH in patients with subclinical hypothyroidism. │ Clinical Endocrinology (Oxf) │ 83,923-930 (共著)
10.	2014/06	マクロプロラクチン血症の病態 │ 最新医学 │ 69 (6),123-131 (共著)
11.	2014/01	Development of insulin antibodies and changes in titers over a long-term period in patients with type 2 diabetes │ Clinica Chimica Acta │ 433 (135-138) (共著)
12.	2013/06	Possible involvement of matrix metalloproteinase-3 in the pathogenesis of macroprolactinaemia in some patients with rheumatoid arthritis │ European Journal of Endocrinology │ 169,1-8 (共著)
13.	2013/01	Letter Regarding Clinical Practice Guideline: Diagnosis and Treatment of Hyperprolactinemia. │ Journal of Clinical Endocrinology and Metabolism │ ,January 14 (共著)
14.	2012	Macroprolactinemia: Diagnostic, Clinical, and Pathogenic Significance. │ Clinical and Developmental Immunology │ Volume 2012 (Article ID 167132),7 pages (共著)
15.	2012	The natural history of macroprolactinaemia │ European Journal of Endocrinology │ 166,625-629 (共著)
16.	2011	Excessive expression of hippocampal Ezrin is induced by intrastriatal injection of 6-hydroxydopamine │ Biol Pharm Bull │ 34,1753-1758 (共著)
17.	2011	特集：プロラクチンの生理.病理の新展開「マクロプロラクチン血症」 │ HORMONE FRONTIER IN GYNECOLOGY 2011 │ 18 (3),57-65 (共著)
18.	2011	特集「下垂体疾患の診断と治療―現状と課題―」高プロラクチン血症の内分泌診断 │ ホルモンと臨床 │ 58 (9),19-24 (共著)
19.	2010	Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up │ Clin Endocrinol (Oxf) 2010 │ 73,792-797 (共著)
20.	2009	Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system │ Growth Hormone & IGF Research │ 19,187-197 (単著)
21.	2009	Macroprolactinaemia: Prevalence and Aetiologies in a Large Group of Hospital Workers │ Clinical Endocrinology (Oxf) │ 71,702-708 (共著)
22.	2008	Anti-prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia │ Clin Endocrinol (Oxf) │ 68,72-76 (共著)
23.	2008	アルツハイマー病病の基礎と臨床ー現状と課題（アミロイドβ蛋白の神経毒性機構） │ 日本薬理学会雑誌 │ 131,326-332 (共著)
24.	2007	An Infant Case of Macroprolactinemia with Transient Idiopathic Central Precocious Puberty. │ Endocrine Journal │ 54,825-828 (共著)
25.	2007	Development of anti-PRL (prolactin) autoantibodies by homologous PRL in rats: a model for macroprolactinemia. │ Endocrinology │ 148,2465-2470 (共著)
26.	2007	Down-regulation of Cl- pump ClP55 subunit induced enhancement of glutamate neurotoxicity in cultured rat hippocampal neurons. │ Brain Research │ 1130,235-238 (共著)
27.	2007	Soybean-derived phosphatidylinositol inhibits in vivo low concentrations of amyloid beta protein-induced degeneration of hippocampal neurons in V337M human tau-expressing mice. │ Life Sciences │ 80,1971-1976 (共著)
28.	2006	Anti-prolactin (PRL) autoantibody binding sites (epitopes) on PRL molecule in macroprolactinemia. │ Journal of Endocrinology │ 190,287-293 (共著)
29.	2006	プロラクチン自己抗体により高プロラクチン血症を呈した症例に関する検討 │ ホルモンと臨床 │ 54,18-22 (共著)
30.	2006	γ-Aminobutyric acid (GABA)-C receptor stimulation increases prolactin (PRL) secretion in cultured anterior pituitary cells. │ Biochemical Pharmacology │ 71,1705-1710 (共著)
31.	2005	Anxiolytic agent, dihydrohonokiol-B, recovers amyloid ß protein-induced neurotoxicity in cultured rat hippocampal neurons. │ Neuroscience Letters │ 384,44-47 (共著)
32.	2005	Effects of growth hormone on the differentiation of mouse B-lymphoid precursors. │ Journal of Pharmacological Sciences │ 97,408-416 (共著)
33.	2005	Immunoglobulin G subclasses and prolactin (PRL) isoforms in macroprolactinemia due to anti-PRL autoantibodies. │ Journal of Clinical Endocrinology and Metabolism │ 90,3036-3044 (共著)
34.	2004	Expression and roles of Cl- channel ClC-5 in cell cycles of myeloid cells. │ Biochemical and Biophysical Research Communications │ 317,192-197 (共著)
35.	2004	Single cell RT-PCR demonstrates differential expression of GABAC receptor rho subunits in rat hippocampal pyramidal and granule cells. │ Molecular Brain Research │ 123,1-6 (共著)
36.	2004	Suppression of cell proliferation with induction of p21 by Cl- channel blockers in human leukemic cells. │ European Journal of Pharmacology │ 488,27-34 (共著)
37.	2003	Macroprolactinemia: a new cause of cause hyperprolactinemia. (Current Perspective) │ Journal of Pharmacological Sciences │ 92,171-177 (単著)
38.	2002	Expression of swelling and/or pH-regulated chloride channels (ClC-2, 3, 4 and 5) in human leukemic and normal immune cells. │ Life Sciences │ 70,1383-1394 (共著)
39.	2002	Phosphatidylinositol and PI-4-monophosphate recover amyloid β protein-induced inhibition of Cl--ATPase. │ Life Sciences │ 72,455-463 (共著)
40.	2002	Protective effects of estradiol against amyloid β protein-induced inhibition of neuronal Cl--ATPase activity. │ Neuropharmacology │ 43,1297-1304 (共著)
41.	2001	Amyloid β proteins inhibit Cl--ATPase activity in cultured rat hippocampal neurons. │ Journal of Neurochemistry │ 78,569-576 (共著)
42.	2001	Cl--ATPase in rat brain and kidney. │ Journal of Experimental Zoology Part A-Comparative Experimental Biology │ 289,224-231 (共著)
43.	2001	Developmental changes in Cl--ATPase activity in rat brains. │ Neuroscience Letters │ 302,101-104 (共著)
44.	2001	GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. │ Journal of Clinical Endocrinology and Metabolism │ 86,4284-4291 (共著)
45.	2001	Molecular cloning and characterization of the Cl-pump-associated 55kDa protein in rat brain. │ Biochemical and Biophysical Research Communications │ 289,363-371 (共著)
46.	2000	mRNA expression of kidney-specific ClC-K1 chloride channel in single-cell reverse transcription-polymerase chain reaction analysis of outer hair cells of rat cochlea. │ Neuroscience Letters │ 290,76-78 (共著)
47.	2000	高アンモニア血症の病態生理 │ 外科と代謝・栄養 │ 34,27-34 (共著)
48.	1999	Human lymphocytes express hGH-N gene transcripts of 22kDa, 20kDa and minor forms of GH but not hGH-V gene. │ European Journal of Endocrinology │ 141,413-418 (共著)
49.	1999	Lithium decreases Cl--ATPase activity and increases intracellular Cl- concentration in cultured rat hippocampal neurons. │ Brain Research │ 821,530-534 (共著)
50.	1999	Single-cell RT-PCR demonstrates expression of voltage-dependent chloride channels (ClC-1, ClC-2 and ClC-3) in outer hair cells of rat cochlea. │ Brain Research │ 838,166-170 (共著)
51.	1998	Antiserum against Cl- pump complex recognizes 51 kDa protein, a possible catalytic unit in the rat brain. │ Neuroscience Letters │ 15,371-375 (共著)
52.	1998	Cl--ATPase and Na+/K+-ATPase activities in Alzheimer's disease brains. │ Neuroscience Letters │ 254,141-144 (共著)
53.	1998	Immunological aspects of human growth hormone and prolactin. │ Domestic Animal Endocrinology │ 15,371-375 (共著)
54.	1998	プロラクチン(PRL)自己抗体を有する無症候性高PRL血症について │ ホルモンと臨床内分泌興味ある症例第32集 │ 46,28-30 (共著)
55.	1997	Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL -immunoglobulin G complex. │ Journal of Clinical Endocrinology and Metabolism │ 82,3107-3110 (共著)
56.	1996	131I 治療を頻回に施行した甲状腺癌転移例の臨床的検討 │ 日本内分泌学会雑誌 │ 72,457-466 (共著)
57.	1996	Long-term clinical course of two cases of lymphocytic adenohypophysitis. │ Endocrine Journal │ 43,433-440 (共著)
58.	1996	The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies. │ Journal of Clinical Endocrinology and Metabolism │ 81,586-590 (単著)
59.	1995	Immunoglobulin G can cross-react with glucagon antisera and cause spuriously high plasma glucagon level. │ Endocrine Journal │ 42,455-460 (共著)
60.	1995	ビーズ固相を用いたイムノラジオメトリックアッセイによるサイログロブリンの測定と臨床的評価 │ 医学と薬学 │ 33,1363-1370 (共著)
61.	1995	長期間治療中に甲状腺ホルモン自己抗体の消長を認めた甲状腺疾患の三例 │ 日本内分泌学会雑誌 │ 71,695-708 (共著)
62.	1995	標識抗体法 (Amerlex-MAB FT3)による血清FT3濃度の測定 │ 医学と薬学 │ 34,549-559 (共著)
63.	1994	123I-MIBG シンチグラフィーによる neural crest tumor の検出 │ 核医学 │ 31,1357-1364 (共著)
64.	1994	Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody. │ European Journal of Endocrinology │ 130,438-445 (共著)
65.	1994	Ectopic prolactinoma on MRI. │ Journal of Computer Assisted Tomography │ 18,936-938 (共著)
66.	1994	Effects of anti-prolactin autoantibodies on serum prolactin measurements. │ European Journal of Endocrinology │ 130,434-437 (共著)
67.	1994	Insulinoma with normal plasma insulin concentrations and insulin/glucose ratios during hypoglycemic episodes. │ Internal Medicine │ 33,813-816 (共著)
68.	1994	Spontaneous growth hormone (GH) secretion by unstimulated human lymphocytes and the effects of GH-releasing hormone and somatostatin. │ Journal of Clinical Endocrinology and Metabolism │ 79,1678-1680 (共著)
69.	1994	バセドウ病に合併した甲状腺原発悪性リンパ腫の１例 │ ホルモンと臨床 │ 42,865-868 (共著)
70.	1994	血清および腹水サイログロブリンが高値を示したStruma Ovarii の１例 │ ホルモンと臨床 │ 42,753-759 (共著)
71.	1994	標識抗T4モノクローナル抗体を用いた血中FT4の測定 │ 核医学 │ 31,379-392 (共著)
72.	1993	A case of late-onset congenital adrenal hyperplasia due to partial 3β-hydroxysteroid dehydrogenase deficiency. │ Endocrine Journal │ 40,107-109 (共著)
73.	1993	Growth hormone (GH) secretion from human lymphocytes is up-regulated by GH, but not affected by insulin-like growth factor-I. │ Journal of Clinical Endocrinology and Metabolism │ 76,937-939 (共著)
74.	1993	Is growth hormone associated with diabetic retinopathy? │ Journal of Diabetes and its Complications │ 7,12-14 (共著)
75.	1993	Superior vena cava syndrome due to Graves’ disease. │ Internal Medicine │ 32,80-83 (共著)
76.	1993	サイログロブリン抗体陽性の患者における血中サイログロブリン濃度の検討ー第２報臨床検討 │ ホルモンと臨床 │ 41,111-121 (共著)
77.	1993	サイログロブリン抗体陽性の患者における血中サイログロブリン濃度の検討テロイドパルス療法により一過性四肢麻痺を来たしたバセドウ病眼球突出症の２例 │ ホルモンと臨床 │ 41,583-586 (共著)
78.	1993	ビーズ固相を用いたイムノラジオメトリックアッセイによるサイログロブリンの測定と臨床的評価ー第１報基礎検討 │ ホルモンと臨床 │ 41,103-110 (共著)
79.	1992	A normal ovulatory woman with hyperprolactinemia: presence of anti-prolactin autoantibody and the regulation of prolactin secretion. │ Acta Endocrinologica │ 126,497-500 (共著)
80.	1992	Autoantibody to human prolactin in patients with idiopathic hyperprolactinemia. │ Journal of Clinical Endocrinology and Metabolism │ 75,1226-1229 (共著)
81.	1992	Growth hormone binding protein in Werner's syndrome. │ Clinical Endocrinology │ 36,351-353 (共著)
82.	1992	Hypokalemic paralysis associated with distal renal tubular acidosis. │ Internal Medicine │ 31,662-665 (共著)
83.	1992	Serum growth hormone-binding protein, insulin-like growth factor-I, and growth hormone in patients with liver cirrhosis. │ Metabolism │ 41,377-381 (共著)
84.	1992	甲状腺分化癌の遠隔転移に対する131I 治療間隔の検討 │ ホルモンと臨床 │ 40,727-732 (共著)
85.	1992	手術前後の131I-MIBGシンチグラフィが有用であった褐色細胞腫の１例 │ 臨床放射線 │ 37,625-628 (共著)
86.	1992	著明な低K血症性ミオパチーが診断の端緒となった遠位尿細管性アシドーシスの２例 │ ホルモンと臨床内分泌興味ある症例第20集 │ 40,198-201 (共著)
87.	1992	難聴および高CPK血症を伴ったfamilial idiopathic hypoparathyroidism の２症例 │ ホルモンと臨床内分泌興味ある症例第19集 │ 40,128-130 (共著)
88.	1991	131I 全身シンチグラフィによる甲状腺分化癌転移巣の早期診断と131I治療 │ 核医学 │ 28,247-259 (共著)
89.	1991	Effects of sex and age on serum GH binding protein levels in normal adults. │ Clinical Endocrinology │ 35,295-297 (共著)
90.	1991	Gamma Coat FT4 Kit （改良法）による血中遊離サイロキシン濃度の測定 │ ホルモンと臨床 │ 39,643-650 (共著)
91.	1991	LH- and FSH-secreting pituitary adenoma in a postmenopausal woman. │ Endocrinologica Japonica │ 38,393-396 (共著)
92.	1991	リンパ球性下垂体炎の疑いで経過観察中に出産後無痛性甲状腺炎を合併した１例 │ 日本内分泌学会雑誌 │ 67,222-229 (共著)
93.	1991	巨大な甲状腺腫を呈した乳頭癌の１例におけるエタノール注入療法の効果 │ ホルモンと臨床 │ 39,1293-1296 (共著)
94.	1991	原発性甲状腺機能低下症における血中ミオシン濃度の検討 │ 核医学 │ 28,1515-1520 (共著)
95.	1991	甲状腺乳頭癌の遠隔転移と頚部リンパ節転移 │ 耳鼻臨床 │ 39,1293-1296 (共著)
96.	1991	代謝生骨疾患における骨塩量の測定 │ 核医学 │ 28,1529-1535 (共著)
97.	1991	糖尿病者に見られるlimited joint mobility に関する臨床的調査 │ 糖尿病 │ 34,1039-1046 (共著)
98.	1990	Basedow 病を合併した末端肥大症の１例 │ ホルモンと臨床内分泌興味ある症例第14集 │ 38,66-69 (共著)
99.	1990	Clofibrate-induced myopathy in a patient with primary hypothyroidism. │ Japanese Journal of Medicine │ 29,545-547 (共著)
100.	1990	DPA装置による骨塩定量 │ 映像情報Medical │ 22,1217-1222 (共著)
101.	1990	Evaluation of activity in postoperative acromegalics: plasma growth hormone levels during oral glucose tolerance test, daytime blood sampling and urinary GH excretion. │ Endocrinologica Japonica │ 37,629-637 (共著)
102.	1990	Galanin-induced prolactin release in rats: pharmacological evidence for the involvement of alpha-adrenergic and opioidergic mechanisms. │ Brain Research │ 507,321-324 (共著)
103.	1990	Growth hormone and growth hormone binding protein in human urine. │ Kidney International │ 37,951-954 (共著)
104.	1990	Growth hormone responses to oral glucose loading measured by highly sensitive enzyme　immunoassay in normal subjects and patients with glucose intolerance and acromegaly. │ Journal of Clinical Endocrinology and Metabolism │ 70,771-776 (共著)
105.	1990	Immunoreactive growth hormone (GH) secretion by human lymphocytes: augmented release by exogenous GH. │ Biochemical and Biophysical Research Communication │ 168,396-401 (共著)
106.	1990	Secretion of alpha and TSH-beta subunits in patients with acromegaly: an in vivo study. │ Acta Endocrinologica │ 122,729-734 (共著)
107.	1990	Secretory dynamics of growth hormone in an acromegalic patient associated with Graves' disease. │ Journal of Clinical Endocrinology and Metabolism │ 71,1059-1063 (共著)
108.	1990	イムノラジオメトリックアッセイによるヒト成長ホルモンの高感度測定法とその臨床応用 │ 日本内分泌学会雑誌 │ 66,715-725 (共著)
109.	1989	Possible involvement of endogenous opioid peptides in prolactin secretion induced by alpha 2-adrenergic stimulation in rats. │ Proceedings of the Society for Experimental Biology and Medicine │ 192,105-108 (共著)
110.	1989	Possible mechanisms involved in growth hormone secretion induced by galanin in the rat. │ Endocrinology │ 124,1224-1229 (共著)
111.	1989	Urinary excretion of human growth hormone: daily variation and relationship with albumin and alpha 1-microglobulin in urine. │ Acta Endocrinologica │ 121,533-537 (共著)
112.	1988	Nocturnal urinary growth hormone excretion in children with short stature. │ Acta Endocrinologica 119: 113-117, 1988. │ 119,113-117 (共著)
113.	1988	Urinary growth hormone levels measured by ultrasensitive enzyme immunoassay in patients with renal insufficiency. │ Journal of Clinical Endocrinology and Metabolism │ 66,727-732 (共著)
114.	1988	下垂体性小人症の診断における超高感度EIAによる早朝一回尿中GH測定の意義 │ ホルモンと臨床 │ 36,435-438 (共著)
115.	1988	超高感度EIAによって測定される尿中GHの安定性と存在様式 │ ホルモンと臨床 │ 36,431-434 (共著)
116.	1988	超高感度の酵素抗体法(EIA)による尿中ヒト成長ホルモン(hGH)測定に関する基礎的検討 │ 日本内分泌学会雑誌 64: 78-92, 1988. │ 64,78-92 (共著)
117.	1987	[Immunoassay新しい展開] 高感度成長ホルモン(GH)測定と臨床応用 │ ホルモンと臨床35: 699-705, 1987. │ 35,699-705 (共著)
118.	1986	[脳とドパミン] 内分泌疾患とドパミン │ Pharma Medica　4: 85-90, 1986. │ 4,85-90 (共著)
119.	1986	CT diagnosis of periureteric venous ring. │ Journal of Computer Assisted Tomography 10: 1078-1079, 1986. │ 10,1078-1079 (共著)
120.	1985	Extramedullary plasmacytoma of the parotid gland: report of a case and review of the literature. │ Tohoku Journal of Experimental Medicine 146: 469-478, 1985. │ 146,469-478 (共著)